Stocks Health care GNPX
NASDAQ · Health careGenprex, Inc. (GNPX)
It posted a net loss of $16.5M. At June 30, 2026 it held $15.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about Genprex, Inc.
- Net worth
- Genprex, Inc. has a market value (market cap) of $1.8M at the latest share price, and shareholders' equity of $14.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2024 revenue was $0, with a net loss of $21.1M.
- Cash flow
- In fiscal 2025 operations used $15.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Genprex, Inc.'s next report is expected around November 16, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Genprex, Inc. does
Genprex, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GNPX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$16.2M | -$17.40 | n/a |
| 2024 | $0 | -$21.1M | -$266.89 | n/a |
| 2023 | $0 | -$30.9M | -$1,127.54 | n/a |
| 2022 | $0 | -$23.7M | -$989.59 | -$17.6M |
| 2021 | $0 | -$20.7M | -$20.99 | -$14.3M |
| 2020 | $0 | -$17.9M | -$25.49 | -$14M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Genprex, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 18, 2026Other event 8-K
- August 14, 2026
- August 5, 2026
- August 3, 2026Other event 8-K
- July 30, 2026
- July 14, 2026
- June 26, 2026
- June 22, 2026Other event 8-K
- June 18, 2026
- June 12, 2026
Insider trades
What the people running Genprex, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| April 14, 2026 | Longnecker Brent MDirector | Sold | 8 | $9.8 |
| April 14, 2026 | Longnecker Brent MDirector | Soldindirect | 10 | $12.3 |
| February 27, 2026 | Confer Ryan M.President, CEO and CFO, Director | Shares withheld for tax | 9,330 | $18.7K |
| February 27, 2026 | Berger Mark StanleyChief Medical Officer | Shares withheld for tax | 7,168 | $14.3K |
| December 22, 2025 | Wilson William R Jr.Director | Received as pay | 9,000 | - |
| December 22, 2025 | Longnecker Brent MDirector | Received as pay | 9,000 | - |
| December 22, 2025 | Confer Ryan M.President, CEO and CFO, Director | Received as pay | 45,000 | - |
| December 22, 2025 | Berger Mark StanleyChief Medical Officer | Received as pay | 28,500 | - |
Who owns GNPX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
5 insiders reported holding 85,494 shares in total, about $186.4K at the last price.
| Holder | Shares |
|---|---|
| Confer Ryan M.President, CEO and CFO, Director | 36,331 |
| Berger Mark StanleyChief Medical Officer | 21,692 |
| Longnecker Brent MDirector | 9,157 |
| Moreno Toscano Jose AntonioDirector | 9,157 |
| Wilson William R Jr.Director | 9,157 |
Questions about GNPX
What does Genprex, Inc. do?
Genprex, Inc. is a company in the Health care sector, listed on NASDAQ as GNPX. Its shares trade on NASDAQ under the ticker GNPX.
What is Genprex, Inc.'s net worth?
Genprex, Inc. has a market value (market cap) of $1.8M at the latest share price, and shareholders' equity of $14.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Genprex, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $16.5M.
When did Genprex, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from August 18, 2026.
When is Genprex, Inc.'s next earnings report?
Genprex, Inc.'s next report is expected around November 16, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare GNPX with
Follow GNPX
Get an email when Genprex, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Genprex, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.